share_log

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Benzinga ·  Apr 9 20:09

Gainers

  • Acrivon Therapeutics (NASDAQ:ACRV) stock moved upwards by 72.3% to $10.19 during Tuesday's pre-market session. The market value of their outstanding shares is at $230.5 million.
  • Biophytis (NASDAQ:BPTS) stock rose 40.64% to $0.45. The market value of their outstanding shares is at $5.1 million.
  • MyMD Pharmaceuticals (NASDAQ:MYMD) stock rose 33.85% to $3.44. The company's market cap stands at $7.1 million.
  • Addex Therapeutics (NASDAQ:ADXN) stock rose 24.48% to $27.2. The company's market cap stands at $28.8 million.
  • Brainstorm Cell (NASDAQ:BCLI) shares rose 21.06% to $0.88. The market value of their outstanding shares is at $60.4 million.
  • Inspire Veterinary (NASDAQ:IVP) shares moved upwards by 20.64% to $0.06. The market value of their outstanding shares is at $1.7 million. As per the press release, Q4 earnings came out yesterday.

Losers

  • Vincerx Pharma (NASDAQ:VINC) shares declined by 64.7% to $1.69 during Tuesday's pre-market session. The market value of their outstanding shares is at $36.1 million.
  • BioSig Technologies (NASDAQ:BSGM) stock declined by 21.96% to $0.97. The company's market cap stands at $9.0 million.
  • Neogen (NASDAQ:NEOG) shares declined by 16.63% to $11.99. The market value of their outstanding shares is at $2.5 billion. As per the press release, Q3 earnings came out today.
  • Tilray Brands (NASDAQ:TLRY) stock decreased by 15.45% to $2.19. The market value of their outstanding shares is at $1.6 billion. As per the press release, Q3 earnings came out today.
  • YS Biopharma Co (NASDAQ:YS) stock decreased by 15.25% to $0.75. The market value of their outstanding shares is at $140.4 million.
  • Etao International Co (NASDAQ:ETAO) stock fell 11.99% to $3.82. The market value of their outstanding shares is at $19.5 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment